Compass Therapeutics competitors
View the competitive landscape for Compass Therapeutics, featuring companies like Genmab, Inhibrx, and Mersana Therapeutics. Mapping a different industry? Browse our competitor database or generate a competitor list for any company.
Clinical-stage oncology company developing antibody-based cancer therapies
compasstherapeutics.comList of Compass Therapeutics competitors
Genmab
Biotechnology company developing differentiated antibody therapeutics for cancer
genmab.comInhibrx
Clinical-stage biopharmaceutical company developing therapeutic antibodies for cancer
inhibrx.comMersana Therapeutics
Clinical-stage company developing antibody-drug conjugates for tumor targeting
mersana.comALX Oncology
Clinical-stage immuno-oncology company developing therapies targeting the CD47 pathway
alxoncology.comAdimab
Biotechnology company specializing in yeast-based antibody discovery and engineering
adimab.comAgenus
Clinical-stage immuno-oncology company focused on antibody and vaccine discovery
agenusbio.comImmunoGen
Biotechnology company developing antibody-drug conjugates for cancer treatment
immunogen.comXencor
Clinical-stage company developing engineered monoclonal antibodies for cancer treatment
xencor.comHarpoon Therapeutics
Clinical-stage immunotherapy company developing T-cell engaging antibodies
harpoontx.comMacroGenics
Biopharmaceutical company focused on monoclonal antibody-based therapeutics for cancer
macrogenics.com
Follow their latest moves with a real-time news feed and summaries delivered straight to your inbox.
More like Compass Therapeutics & trending lists
Browse competitors related to Compass Therapeutics and other trending companies.
Agenus
WorkerZero
Kepler Communications
Renuology
friend
npm
Ramaco Resources
DataBahn
Wiz
Permiso
Exoticool
BmyBrand
Simile
Anyscale
Disney Plus
Zoox
K2 Space
Databahn
MarketAxess
inforcer
Fidelity
Scale
NextClean
Phillips
Economics Observatory
FRAMOS
Opensignal
Ookla
Nesta
ARMotors
ROSAIC
The Garage Studio
Federal Aviation Administration
ONYX
Bertram Capital
Bessemer Trust